留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码
x 关闭 永久关闭

应中央军委要求，2022年9月起，《药学实践杂志》将更名为《药学实践与服务》，双月刊，正文96页；2023年1月起，拟出版月刊，正文64页，数据库收录情况与原《药学实践杂志》相同。欢迎作者踊跃投稿！

肝细胞癌循环肿瘤细胞与肿瘤转移和预后关系的研究

王真,  徐增辉,  郑罗凝,  王颖,  孙保木,  金华君,  钱其军

downloadPDF
文章导航 > 药学实践与服务  > 2015 >  33(2): 159-162,192
王真, 徐增辉, 郑罗凝, 王颖, 孙保木, 金华君, 钱其军. 肝细胞癌循环肿瘤细胞与肿瘤转移和预后关系的研究[J]. 药学实践与服务, 2015, 33(2): 159-162,192. doi: 10.3969/j.issn.1006-0111.2015.02.018
引用本文: 王真, 徐增辉, 郑罗凝, 王颖, 孙保木, 金华君, 钱其军. 肝细胞癌循环肿瘤细胞与肿瘤转移和预后关系的研究[J]. 药学实践与服务, 2015, 33(2): 159-162,192. doi: 10.3969/j.issn.1006-0111.2015.02.018
shu
WANG Zhen, XU Zenghui, ZHENG Luoning, WANG Ying, SUN Baomu, JIN Huajun, QIAN Qijun. Study on the relationship of circulating tumor cells and metastasis and prognosis of hepatocellular carcinoma[J]. Journal of Pharmaceutical Practice and Service, 2015, 33(2): 159-162,192. doi: 10.3969/j.issn.1006-0111.2015.02.018
Citation: WANG Zhen, XU Zenghui, ZHENG Luoning, WANG Ying, SUN Baomu, JIN Huajun, QIAN Qijun. Study on the relationship of circulating tumor cells and metastasis and prognosis of hepatocellular carcinoma[J]. Journal of Pharmaceutical Practice and Service, 2015, 33(2): 159-162,192. doi: 10.3969/j.issn.1006-0111.2015.02.018
shu

肝细胞癌循环肿瘤细胞与肿瘤转移和预后关系的研究

doi: 10.3969/j.issn.1006-0111.2015.02.018
  • 1.

    东方肝胆外科医院病毒基因治疗实验室, 上海 200438;东方肝胆外科医院生物治疗科, 上海 200438

  • 2.

    东方肝胆外科医院病毒基因治疗实验室, 上海 200438

  • 3.

    浙江理工大学生命科学学院, 杭州 310018

  • 4.

    东方肝胆外科医院中西医结合科, 上海 200438

  • 5.

    东方肝胆外科医院病毒基因治疗实验室, 上海 200438;东方肝胆外科医院生物治疗科, 上海 200438;浙江理工大学生命科学学院, 杭州 310018

基金项目: 国家自然科学基金(No.81301307);国家传染病防治重大专项(No.2013ZX10002-010-007);上海细胞治疗工程技术研究中心科研基金(No.12DZ2251600);上海市卫生局科研基金(No.20114179)

Study on the relationship of circulating tumor cells and metastasis and prognosis of hepatocellular carcinoma

  • 1.

    Laboratory of Gene and Viral Therapy, Eastern Hepatobiliary Surgery Hospital, Shanghai 200438, China;Department of Biotherapy, Eastern Hepatobiliary Surgery Hospital, Shanghai 200438, China

  • 2.

    Laboratory of Gene and Viral Therapy, Eastern Hepatobiliary Surgery Hospital, Shanghai 200438, China

  • 3.

    College of Life Sciences, Zhejiang Sci-Tech University, Hangzhou 310018, China

  • 4.

    Department of Integration of Traditional Chinese and Western medicine, Eastern Hepatobiliary Surgery Hospital, Shanghai 200438, China

  • 5.

    Laboratory of Gene and Viral Therapy, Eastern Hepatobiliary Surgery Hospital, Shanghai 200438, China;Department of Biotherapy, Eastern Hepatobiliary Surgery Hospital, Shanghai 200438, China;College of Life Sciences, Zhejiang Sci-Tech University, Hangzhou 310018, China

  • 摘要: 目的 研究肝细胞癌(hepatocellular carcinoma, HCC)患者外周血循环肿瘤细胞(circulating tumor cell, CTC)与肿瘤转移和预后的关系。 方法 选取35例肝细胞癌患者, 应用密度梯度离心法联合免疫磁珠阴性富集法富集CTC, 然后利用染色体荧光原位杂交和细胞免疫荧光技术进行CTC鉴定并计数, 同时记录临床相关特征, 对数据进行统计学分析。 结果 所有患者均检出CTC, 阳性率为100%, CTC个数均值为(4.1±2.5) 个。对患者进行分组, Ⅰ组的CTC个数<5, Ⅱ组的CTC数量≥5。Ⅰ组、Ⅱ组的CTC数量差异有统计学意义(P=0.001), 患者的性别、年龄与肿瘤转移无关(P=0.581、0.531), CTC的数量与转移及预后有关(P=0.024、0.01),Ⅰ组、Ⅱ组的转移和预后差异有统计学意义。 结论 HCC患者外周血CTC的数量与肿瘤转移及预后有关,CTC的数量≥5时,可能肿瘤更具转移倾向,预后更差,患者生存期更短。
    Abstract: Objective To study the relationship between circulating tumor cells(CTCs) in peripheral blood of the patients with hepatocellular carcinoma (HCC) and its metastasis and prognosis. Methods 35 patients with hepatocellular carcinoma were collected as the research objects.CTCs density were enriched through gradient centrifugation and negative-immunomagnetic methods, then the cells were detected by chromosome fluorescence in situ hybridization combined with immunofluorescence tests to identify CTCs. The clinical characters were recorded and the data were statistically analyzed. Results All the patients were detected CTC positive. The number of CTC was (4.1±2.5).The patients were divided into 2 groups.Group Ⅰ included patients whose CTCs were <5,and others were included in group Ⅱ.The difference between number of group I and group Ⅱ had significant significance(P=0.001); Metastasis had nothing to do with patients' sex and age(P=0.581,0.531); The number of CTCs was related to metastasis and prognosis(P=0.024,0.01),and there was significant statistic significance between group I and group Ⅱ. Conclusion The number of CTCs was related to tumor metastasis.The tumor may be more prone to occur metastasis and may had worse prognosis,and the patients may had shorter life time when the number of CTCs was≥5.
  • [1] Cha C, Fong Y, Jarnagin WR, et al. Predictors and patterns of recurrence after resection of hepatocellular carcinoma[J]. J Am Coll Surg, 2003, 197(5): 753-758.
    [2] Pantel K, Brakenhoff RH. Dissecting the metastatic cascade[J]. Nat Rev Cancer, 2004, 4(6): 448-456.
    [3] Shao C, Liao CP, Hu P, et al. Detection of live circulating tumor cells by a class of near-infrared heptamethine carbocyanine dyes in patients with localized and metastatic prostate cancer[J]. PLoS One, 2014, 9(2): e88967.
    [4] Seeberg LT, Waage A, Brunborg C, et al. Circulating tumor cells in patients with colorectal liver metastasis predict impaired survival[J]. Ann Surg, 2015, 261(1): 164-171.
    [5] Mikulova V, Cabinakova M, Janatkova I, et al. Detection of circulating tumor cells during follow-up of patients with early breast cancer: clinical utility for monitoring of therapy efficacy[J]. Scand J Clin Lab Invest, 2014, 74(2): 132-142.
    [6] Muinelo-Romay L, Vieito M, Abalo A, et al. Evaluation of circulating tumor cells and related events as prognostic factors and surrogate biomarkers in advanced NSCLC patients receiving first-line systemic treatment[J]. Cancers (Basel), 2014, 6(1): 153-165.
    [7] Poveda A, Kaye SB, McCormack R, et al. Circulating tumor cells predict progression free survival and overall survival in patients with relapsed/recurrent advanced ovarian cancer[J]. Gynecol Oncol, 2011, 122(3): 567-572.
    [8] Zigeuner RE, Riesenberg R, Pohla H, et al. Isolation of circulating cancer cells from whole blood by immunomagnetic cell enrichment and unenriched immunocytochemistry in vitro[J]. J Urol, 2003, 169(2): 701-705.
    [9] Wu C, Hao H, Li L, et al. Preliminary investigation of the clinical significance of detecting circulating tumor cells enriched from lung cancer patients[J]. J Thorac Oncol, 2009, 4(1): 30-36.
    [10] Gisselsson D.Refined characterisation of chromosome aberrations in tumours by multicolour banding and electronic mapping resources[J].Methods Cell Sci,2001,23(1-3):23-28.
    [11] Ashworth TR. A case of cancer in which cells similar to those in the tumors were seen in the blood after death[J]. Aust Med J, 1869, 14(146-149.
    [12] Yu M, Bardia A, Wittner BS, et al. Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition[J]. Science, 2013, 339(6119): 580-584.
    [13] Labelle M, Begum S, Hynes RO. Direct signaling between platelets and cancer cells induces an epithelial-mesenchymal-like transition and promotes metastasis[J]. Cancer Cell, 2011, 20(5): 576-590.
    [14] 曹宇勃,许崇安. 循环肿瘤细胞预测肝细胞癌患者临床预后价值的Meta分析[J]. 中国全科医学, 2014, 17(12): 1394-1399.
    [15] Sun YF, Xu Y, Yang XR, et al. Circulating stem cell-like epithelial cell adhesion molecule-positive tumor cells indicate poor prognosis of hepatocellular carcinoma after curative resection[J]. Hepatology, 2013, 57(4): 1458-1468.
  • [1] 黎翔, 代鲜敏, 刘霞, 孙旸.  黄芪甲苷衍生物HHQ16上调α1酸性糖蛋白改善肝细胞脂质沉积 . 药学实践与服务, 2024, 42(4): 141-146. doi: 10.12206/j.issn.2097-2024.202309026
    [2] 方宇昕, 李育, 刘宝姝, 董国强.  磷脂酰肌醇蛋白聚糖-3靶向治疗肝细胞癌的研究进展 . 药学实践与服务, 2023, 41(10): 586-593. doi: 10.12206/j.issn.2097-2024.202307047
    [3] 董雨龙, 娄成, 陈熙昀, 魏炜, 陶晨洁, 韩琴, 袁振刚.  基于网络药理学探讨通关藤抗肝细胞癌的作用机制 . 药学实践与服务, 2023, 41(10): 600-609. doi: 10.12206/j.issn.2097-2024.202212049
    [4] 卢进, 赵新才, 陈蓓蓉, 赵赟, 王婧, 霍炎.  药师对1例转移性乳腺癌术后伴癌痛患者的药学监护 . 药学实践与服务, 2021, 39(4): 359-361. doi: 10.12206/j.issn.1006-0111.202101028
    [5] 赵景昕, 缪朝玉, 徐添颖.  脓毒症生物标志物的最新进展 . 药学实践与服务, 2021, 39(6): 491-498. doi: 10.12206/j.issn.1006-0111.202105040
    [6] 蔡同凯, 杨文胜, 曹永兵, 韩华, 阎澜.  医用透明质酸钠凝胶对肿瘤生长和转移影响的实验研究 . 药学实践与服务, 2020, 38(2): 129-134. doi: 10.3969/j.issn.1006-0111.201911108
    [7] 王治, 王淑娜, 徐添颖, 李志勇, 张赛龙, 缪朝玉.  烟酰胺磷酸核糖转移酶基因编辑对人胚胎干细胞生长影响的研究 . 药学实践与服务, 2019, 37(3): 237-240. doi: 10.3969/j.issn.1006-0111.2019.03.009
    [8] 曹梦雪, 孙凡, 林厚文.  肿瘤干细胞的治疗耐受机制研究进展 . 药学实践与服务, 2017, 35(3): 193-196,247. doi: 10.3969/j.issn.1006-0111.2017.03.001
    [9] 谭海颂, 叶宸, 吴登爽, 鲍一, 刘冰, 何屹, 王林辉.  杨梅酮抑制人肾细胞癌细胞转移的实验研究 . 药学实践与服务, 2017, 35(3): 229-232,237. doi: 10.3969/j.issn.1006-0111.2017.03.009
    [10] 郭玲玲, 丁永梅, 张迁.  肝细胞癌术后复发再次手术1例及文献综述 . 药学实践与服务, 2017, 35(3): 270-274. doi: 10.3969/j.issn.1006-0111.2017.03.019
    [11] 郭玲玲, 仇金荣.  免疫治疗在肝细胞癌治疗中的进展 . 药学实践与服务, 2017, 35(4): 362-366. doi: 10.3969/j.issn.1006-0111.2017.04.019
    [12] 操跃, 杨喜晶, 周福平, 张迁, 钱其军.  DC-CIK与结直肠癌患者预后的关系和影响因素 . 药学实践与服务, 2016, 34(4): 366-371. doi: 10.3969/j.issn.1006-0111.2016.04.022
    [13] 刘悦, 赵亮, 李燕, 朱臻宇, 柴逸峰.  肝细胞性肝癌代谢组学研究进展 . 药学实践与服务, 2013, 31(2): 81-85. doi: 10.3969/j.issn.1006-0111.2013.02.001
    [14] 闫冰, 丁安伟, 张丽.  二至丸水提物对体外肝细胞损伤的保护作用 . 药学实践与服务, 2010, 28(6): 433-439,436.
    [15] 章忱, 程康, 郭炜, 卫洪昌.  麝香保心丸对裸小鼠人结肠癌肝转移模型促血管新生因子及肿瘤生长的影响 . 药学实践与服务, 2007, (5): 295-296,302.
    [16] 孙奎, 姜华.  玄参中苯丙素苷对肝细胞损伤保护作用的研究 . 药学实践与服务, 2002, (4): 234-235.
    [17] 杨以真, 蔡修熙.  促肝细胞生长素治疗各型肝炎疗效的比较 . 药学实践与服务, 1999, (4): 216-218.
    [18] 张夏华, 龚守军.  促肝细胞生长素与肝生素治疗重症肝病的疗效观察 . 药学实践与服务, 1998, (5): 271-273.
    [19] 吴笑春, 崔海影.  应用Fura-2/AM测定大鼠肝细胞内钙离子浓度 . 药学实践与服务, 1995, (3): 139-141.
    [20] 朱蘋香.  治疗重症肝炎的新药——注射用促肝细胞生长素(HGF) . 药学实践与服务, 1993, (2): 82-84.
  • 加载中
WeChat 点击查看大图
计量
  • 文章访问数:  3127
  • HTML全文浏览量:  233
  • PDF下载量:  676
  • 被引次数: 0
出版历程
  • 收稿日期:  2014-11-01
  • 修回日期:  2015-01-29

肝细胞癌循环肿瘤细胞与肿瘤转移和预后关系的研究

doi: 10.3969/j.issn.1006-0111.2015.02.018
  • 1. 东方肝胆外科医院病毒基因治疗实验室, 上海 200438;东方肝胆外科医院生物治疗科, 上海 200438
  • 2. 东方肝胆外科医院病毒基因治疗实验室, 上海 200438
  • 3. 浙江理工大学生命科学学院, 杭州 310018
  • 4. 东方肝胆外科医院中西医结合科, 上海 200438
  • 5. 东方肝胆外科医院病毒基因治疗实验室, 上海 200438;东方肝胆外科医院生物治疗科, 上海 200438;浙江理工大学生命科学学院, 杭州 310018
    • 基金项目:  国家自然科学基金(No.81301307);国家传染病防治重大专项(No.2013ZX10002-010-007);上海细胞治疗工程技术研究中心科研基金(No.12DZ2251600);上海市卫生局科研基金(No.20114179)
  • 收稿日期: 2014-11-01
  • 修回日期: 2015-01-29

摘要: 目的 研究肝细胞癌(hepatocellular carcinoma, HCC)患者外周血循环肿瘤细胞(circulating tumor cell, CTC)与肿瘤转移和预后的关系。 方法 选取35例肝细胞癌患者, 应用密度梯度离心法联合免疫磁珠阴性富集法富集CTC, 然后利用染色体荧光原位杂交和细胞免疫荧光技术进行CTC鉴定并计数, 同时记录临床相关特征, 对数据进行统计学分析。 结果 所有患者均检出CTC, 阳性率为100%, CTC个数均值为(4.1±2.5) 个。对患者进行分组, Ⅰ组的CTC个数<5, Ⅱ组的CTC数量≥5。Ⅰ组、Ⅱ组的CTC数量差异有统计学意义(P=0.001), 患者的性别、年龄与肿瘤转移无关(P=0.581、0.531), CTC的数量与转移及预后有关(P=0.024、0.01),Ⅰ组、Ⅱ组的转移和预后差异有统计学意义。 结论 HCC患者外周血CTC的数量与肿瘤转移及预后有关,CTC的数量≥5时,可能肿瘤更具转移倾向,预后更差,患者生存期更短。

English Abstract

王真, 徐增辉, 郑罗凝, 王颖, 孙保木, 金华君, 钱其军. 肝细胞癌循环肿瘤细胞与肿瘤转移和预后关系的研究[J]. 药学实践与服务, 2015, 33(2): 159-162,192. doi: 10.3969/j.issn.1006-0111.2015.02.018
引用本文: 王真, 徐增辉, 郑罗凝, 王颖, 孙保木, 金华君, 钱其军. 肝细胞癌循环肿瘤细胞与肿瘤转移和预后关系的研究[J]. 药学实践与服务, 2015, 33(2): 159-162,192. doi: 10.3969/j.issn.1006-0111.2015.02.018
shu
WANG Zhen, XU Zenghui, ZHENG Luoning, WANG Ying, SUN Baomu, JIN Huajun, QIAN Qijun. Study on the relationship of circulating tumor cells and metastasis and prognosis of hepatocellular carcinoma[J]. Journal of Pharmaceutical Practice and Service, 2015, 33(2): 159-162,192. doi: 10.3969/j.issn.1006-0111.2015.02.018
Citation: WANG Zhen, XU Zenghui, ZHENG Luoning, WANG Ying, SUN Baomu, JIN Huajun, QIAN Qijun. Study on the relationship of circulating tumor cells and metastasis and prognosis of hepatocellular carcinoma[J]. Journal of Pharmaceutical Practice and Service, 2015, 33(2): 159-162,192. doi: 10.3969/j.issn.1006-0111.2015.02.018
shu

    全文HTML

参考文献 (15)

目录

    /

    返回文章
    返回

    版权所有：《药学实践与服务》编辑委员会

    主管、主办: 中国人民解放军海军军医大学地址: 上海市杨浦区国和路325号邮政编码: 200433

    电话: （021）81871324,81871397 E-mail: yxsjzzs@163.com

    网站备案号 沪ICP备05003363号-1

    本系统由 北京仁和汇智信息技术有限公司 开发    百度统计